NCT04597203

Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Mahidol University · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study aims to assess the efficacy and safety of using combination of 755-nm picosecond alexandrite laser and 2% hydroquinone compared with 2% hydroquinone alone for the treatment of melasma: A randomized split-face controlled trial

Conditions

• Melasma

Interventions

Type	Name	Description
DEVICE	755-nm picosecond alexandrite laser with topical 2% hydroquinone	treatment one side of the face with 755-nm picosecond alexandrite laser with topical 2% hydroquinone
DRUG	topical 2% hydroquinone	treatment one side of the face with topical 2% hydroquinone

Timeline

• Start date: 2020-10-01
• Primary completion: 2021-01-01
• Completion: 2021-02-01
• First posted: 2020-10-22
• Last updated: 2020-10-23

Locations

1 site across 1 country: Thailand